Clinical Trials Logo

Clinical Trial Summary

The rationale of the study is to provide evidence on the efficacy and safety of Emodepside in adults infected with Trichuris trichiura and hookworm.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05017194
Study type Interventional
Source Swiss Tropical & Public Health Institute
Contact
Status Completed
Phase Phase 2
Start date August 2, 2021
Completion date December 10, 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT03261596 - Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana Phase 4
Completed NCT05538767 - Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm Phase 2
Completed NCT03527745 - Albendazole Dose Finding and Pharmacokinetics in Children and Adults Phase 2
Not yet recruiting NCT06188715 - Efficacy and Safety of MOX/ALB Co-administration in SAC Phase 3
Active, not recruiting NCT04227834 - Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education N/A
Completed NCT04700423 - Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration Phase 2/Phase 3
Active, not recruiting NCT03172975 - Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection Phase 2
Not yet recruiting NCT06184399 - Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC Phase 2
Completed NCT04726969 - Efficacy and Safety of MOX/ALB Co-administration Phase 3
Completed NCT03995680 - Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm Phase 2
Completed NCT01163877 - Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma N/A